Mail-order abortion is preserved, for now: "We are pleased that a safe and effective drug Americans depend on will continue to be available while this litigation proceeds," a spokesperson for Danco Laboratories (makers of mifepristone) said in the wake of the Supreme Court deciding to grant a stay to a federal appeals court decision that had briefly required patients seeking abortions to make an in-person visit to a provider vs. getting the drugs dispensed by mail.
Pills are used in more than 60 percent of abortions nowadays. This decision allows them to be distributed by mail in the meantime while litigation continues to unfold.
